Lipids and pulmonary function in the Third National Health and Nutrition Examination Survey

被引:81
作者
Cirillo, DJ [1 ]
Agrawal, Y [1 ]
Cassano, PA [1 ]
机构
[1] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA
关键词
antioxidants; apoproteins; cholesterol; forced expiratory volume; lipoproteins; HDL; LDL;
D O I
10.1093/aje/155.9.842
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Studies considering the association between total cholesterol and noncardiovascular mortality, particularly from respiratory disease, yield inconclusive findings. To explore this question, the relation of lipids to pulmonary function, specifically forced expiratory volume in 1 second (FEV1), was investigated in the Third National Health and Nutrition Examination Survey. Conducted in the United States in 1988-1994 among adults aged greater than or equal to17 years, this survey measured serum lipids, FEV1, and confounding factors including smoking and antioxidants. Multiple linear regression analysis explored the relation of FEV1/height(2) to low density lipoprotein (LDL) cholesterol, high density lipoprotein (HDL) cholesterol, and their respective apolipoproteins (apo) B and A-I. A standard deviation increase in HDL cholesterol or apo A-I was associated with an FEV1 increase of 43 ml (95% confidence interval (CI): 30, 56) or 29 ml (95% CI: 11, 47), respectively, for an average-height adult. A standard deviation increase in LDL cholesterol or apo B was associated with an FEV1 decrease of -24 ml (95% CI: -43, -5) or -53 ml (95% CI: -74, -32), respectively, adjusted for serum antioxidant status. The lipid subfractions were differentially associated with FEV1 consistent with the possibility that LDL cholesterol contributes to endogenous oxidative burden while HDL cholesterol attenuates inflammatory tissue damage. Whether these associations are causal remains to be determined.
引用
收藏
页码:842 / 848
页数:7
相关论文
共 27 条
[1]  
[Anonymous], 1994, VIT HLTH STAT, V1
[2]  
BACHORIK PS, 1994, CLIN CHEM, V40, P1915
[3]   Medical progress: Chronic obstructive pulmonary disease. [J].
Barnes, PJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (04) :269-280
[4]   EVIDENCE FOR INFLAMMATION AS A CAUSE OF HYPOCHOLESTEROLEMIA IN OLDER-PEOPLE [J].
ETTINGER, WH ;
HARRIS, T ;
VERDERY, RB ;
TRACY, R ;
KOUBA, E .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1995, 43 (03) :264-266
[5]   WILL LOWERING POPULATION-LEVELS OF SERUM-CHOLESTEROL AFFECT TOTAL MORTALITY - EXPECTATIONS FROM THE HONOLULU-HEART-PROGRAM [J].
FRANK, JW ;
REED, DM ;
GROVE, JS ;
BENFANTE, R .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1992, 45 (04) :333-346
[6]  
FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
[7]   Low lipid concentrations in critical illness: Implications for preventing and treating endotoxemia [J].
Gordon, BR ;
Parker, TS ;
Levine, DM ;
Saal, SD ;
Wang, JCL ;
Sloan, BJ ;
Barie, PS ;
Rubin, AL .
CRITICAL CARE MEDICINE, 1996, 24 (04) :584-589
[8]  
Gunter E.W., 1996, LAB PROCEDURES USED
[9]   Spirometric reference values from a sample of the general US population [J].
Hankinson, JL ;
Odencrantz, JR ;
Fedan, KB .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (01) :179-187
[10]   Cholesterol lowering with statin drugs, risk of stroke, and total mortality - An overview of randomized trials [J].
Hebert, PR ;
Gaziano, JM ;
Chan, KS ;
Hennekens, CH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 278 (04) :313-321